Replies to post #9640 on Xeriant Inc (XERI)

[Lebbe1]

2 things that come into my mind:
- they put everything ‘on hold’ for the merger agreement, except for Movychem.
Could mean they have some large deals they may be working on. Else why not put that on hold as well,
in order to focus 100% on the merger agreement.
- you could be right that they work directly with Movychem.
If they have large/multiple deals in the US that may be in the works, why pass through Xeriant Europe
and leave some of the sales margin there?
I would think that Movychem/Xeriant Europe would only agree on that if the deal Xeriant has is big.

I hope that, with the 10Q out of the way, the company will now focus on closing certain things and start communicating on them.

[Smartypants2]

Xeriant Europe seems to basically be a sales operation that relies (as you said) on XERI to "get it done." Likewise, Movychem appears to be a sophisticated R&D operation that focuses on "green" technology solutions but needs XERI's funding for IP protection and additional help in further product development (including all those product tests by international manufacturers), not to mention commercialization efforts. XERI has bolstered its advisory board to better support Movychem and now seems to have a clear path to additional funding (ie, Maxim's $100 million funding commitment) -- making a direct relationship to Movychem an obvious choice. It now appears that XERI's master strategy is falling into place.

[SurgeGuy2.0]

Why is the CEO diluting Millions of shares a month? Outstanding Shares now 362,387,770

[SurgeGuy2.0]

Only scam and momentum traders will trade $XERI. Anyone doing real serious DD of this QB stock can see the history of false go-nowhere company news releases from its CEO Snuffy Duffy.